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Summary
Both the discovery of the DYT1 gene on chromosome
9q34 in autosomal dominant early-onset torsion dys-
tonia and the detection of linkage for one form of adult-
onset focal dystonia to chromosome 18p (DYT7) in a
family from northern Germany provide the opportunity
to further investigate genetic factors in the focal dys-
tonias. Additionally, reports of linkage disequilibrium
between several chromosome 18 markers and focal dys-
tonia, both in sporadic patients from northern Germany
and in members of affected families from central Europe
suggest the existence of a founder mutation underlying
focal dystonia in this population. To evaluate the role
of these loci in focal dystonia, we tested 85 patients from
northern Germany who had primary focal dystonia,
both for the GAG deletion in the DYT1 gene on chro-
mosome 9q34 and for linkage disequilibrium at the
chromosome 18p markers D18S1105, D18S1098,
D18S481, and D18S54. None of these patients had the
GAG deletion in the DYT1 gene. Furthermore, Hardy-
Weinberg analysis of markers on 18p in our patient pop-
ulation and in 85 control subjects from the same region
did not support linkage disequilibrium. Taken together,
these results suggest that most cases of focal dystonia in
patients of northern German or central European origin
are due neither to the GAG deletion in DYT1 nor to a
proposed founder mutation on chromosome 18p but
must be caused by other genetic or environmental
factors.
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Introduction
Recent advances in the molecular genetics of different
forms of dystonia provide the opportunity to investigate
the role of known dystonia genes in idiopathic (both
hereditary and sporadic) focal dystonia (for review, see
Gasser 1997; Mu¨ller et al. 1998). TheDYT1 gene (MIM
128100), located on chromosome 9q34 and responsible
for the majority of cases of autosomal dominantly in-
herited early-onset torsion dystonia, has recently been
identified (Ozelius et al. 1997). Most individuals with
this syndrome share a unique 3-bp (GAG) deletion in
the DYT1 gene, resulting in loss of one of a pair of
glutamic acid residues in a conserved region of a novel
ATP-binding protein (Ozelius et al. 1997). Most of the
patients with this mutation present with early-onset gen-
eralized dystonia (Bressman et al. 1994a); however, some
features of this condition overlap the phenotypic spec-
trum of adult-onset (focal) types of dystonia. For ex-
ample, a carrier of this DYT1 mutation has been de-
scribed with only focal dystonia of the neck, starting at
age 34 years (Bressman et al. 1994a), and we examined
another patient with the GAG deletion and focal dys-
tonia of the jaw, which started in her 60s (authors’ un-
published observation).
A gene causing adult-onset focal dystonia (DYT7
[MIM 602124]) has been mapped to chromosome 18p
in one large family (family K) from northern Germany
(Leube et al. 1996). Fifteen sporadic cases from the same
geographic area and 15 cases among 18 families from
central Europe who have focal dystonia have been re-
ported to share, with affected members of family K, spe-
cific alleles, in a subregion of chromosome 18p, linked
to the disease gene (Leube et al. 1997a, 1997b). This
finding of apparent allelic association led the authors of
those studies to conclude that, because of a founder ef-
fect in this population, most of these apparently sporadic
patients and families have inherited the same mutation
as is seen in family K (Leube et al. 1997a, 1997b). The
primary evidence for this linkage disequilibrium was
seen with the markers D18S1098 and D18S481, which
are ∼1.2 cM apart. We collected 85 patients from north-
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ern Germany, all with adult-onset focal dystonia, and,
with the two microsatellite repeat markers noted above
and two additional flanking microsatellite markers
(D18S1105 and D18S54) covering a region of ∼6 cM,
examined them for the putative founder haplotype in
the DYT7 region on chromosome 18p; 85 patients with
idiopathic Parkinson disease who were from the same
geographic region were used as a control group. In ad-
dition, the dystonia cohort was tested for the GAG de-
letion in the DYT1 gene.
Patients and Methods
Patients
Eighty-five consecutive patients with idiopathic focal
( ) or segmental ( ) dystonia who either vis-n  83 n  2
ited the Neurology Department of Lu¨beck University
Hospital for diagnosis and treatment of dystonia or
gathered at meetings of the local dystonia support
groups in northern Germany were included in our study.
The geographic catchment area comprised the northern-
most province of Germany, Schleswig-Holstein; the city
of Hamburg and its suburbs; and the German coastal
region of the Baltic Sea. Informed consent for clinical
examination and DNA analysis was obtained from each
patient. The clinical manifestations of all patients studied
conformed to published diagnostic criteria of idiopathic
focal dystonia (Fahn et al. 1986). Secondary dystonia
was excluded by history, lack of additional neurological
signs, measurement of copper metabolism, and brain
imaging (computed tomography or magnetic resonance
imaging). In addition, 85 patients with idiopathic Par-
kinson disease who were from the same geographic re-
gion served as a control group.
Identification of the GAG Deletion on Chromosome
9q34
After DNA had been extracted from whole blood, we
used published primers 6418 and 6419 (Ozelius et al.
1997) for PCR amplification across the critical region
of the DYT1 gene. PCR products were resolved in a
denaturing 6% polyacrylamide gel and were visualized
by silver staining (von Deimling et al. 1993). Samples
from affected individuals carrying the GAG deletion dis-
played two distinct bands, of 250 and 247 bp, whereas
noncarriers showed a single 250-bp fragment.
Markers on Chromosome 18p
Genotyping was performed under standard conditions
as specified by Research Genetics, with the following
simple sequence repeat DNA markers: D18S1105–3.2
cM–D18S1098–1.2 cM–D18S481–1.5 cM–D18S54,
spanning a 6-cM region on chromosome 18p (the genetic
distances are from Leube et al. 1997b). PCR products
were analyzed on a LICOR automated sequencer. To
ensure comparison of identical alleles, a control DNA
sample (CEPH [Centre d’E´tude du Polymorphisme Hu-
main] 1331-02) was run for each marker, and alleles
were assigned on the basis of data in table 1 of Leube
et al. (1997b).
Allele Frequencies and Hardy-Weinberg Equilibrium
To assess linkage disequilibrium at each marker, we
compared the allele frequencies for the associated alleles
in our patients and controls with those reported else-
where by Leube et al. (1997a, 1997b). The genetic model
proposed for late-onset focal dystonia is a rare, auto-
somal dominant founder mutation with reduced pene-
trance (Leube et al. 1997a, 1997b). Implicit in thismodel
is the premise that the patients’ genotype will be Dd,
whereas the controls’ genotype will be dd. At a linked
marker locus M, let allele 1 be associated with disease
allele D, and let all other alleles be denoted by “X.” Let
p be the frequency of allele 1 on chromosomes carrying
allele d, and let . Similarly, let r be the fre-q  1 p
quency of allele 1 on chromosomes carrying allele D,
and let . The strength of linkage disequilibriums  1 r
is measured by the parameter d (Bengtsson and Thomson
1981; Hastbacka et al. 1992; Devlin and Risch 1995),
given by . As a consequence, .d  (r p)/q r  p qd
Therefore, according to this model, if we assume that D
is rare, then the genotype frequency distribution in pa-
tients will be pr for 11 homozygotes, for 1Xps qr
heterozygotes, and qs for XX homozygotes (here, “X”
refers to all other alleles, so these individuals are tech-
nically homozygous and heterozygous for all other
alleles).
Feder et al. (1996) have described the use of Hardy-
Weinberg disequilibrium for fine mapping the gene for
hemochromatosis, a heterogeneous recessive disorder,
and also have indicated that this approach could be used
for a dominant disorder with a founder mutation, since
an allele in linkage disequilibrium with the founder mu-
tation will show a heterozygote excess. The extent of
this excess, of course, will depend on the allele frequen-
cies and on the strength of disequilibrium as measured
by d.
Herein we assess the evidence for linkage disequilib-
rium, by examining both (1) the difference, between pa-
tients and controls, in the frequency of the associated,
1 allele and (2) the genotype distribution in patients. We
use a likelihood formulation, as follows. Let , ,n n11 1X
and be the numbers of patients with genotypes 11,nXX
1X, and XX, respectively. We assume Hardy-Weinberg
disequilibrium for the controls, and thus measure only
the number of 1 and X alleles in controls, denoted by
“m1” and “mX,” respectively. The log likelihood of these
data can then be written as
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Table 1













Combined subgroups 85 (100) 38/62 54.4  11.0 (29–76) 9.4  8.0 (1–40) 44.8  12.5 (13–73)
Spasmodic torticollis 62 (72.9) 42/58 53.8  10.8 (29–76) 10.7  8.9 (1–40) 42.8  12.4 (13–65)
Writer’s cramp 9 (10.6) 44/56 51.2  14.3 (33–74) 5.2  3.2 (1–12) 46.0  14.1 (27–73)
Cranial dystonia 12 (14.1) 8/92 58.3  9.0 (45–75) 6.2  2.8 (1–9) 52.1  8.5 (36–67)
Segmental dystonia 2 (2.4) 50/50 62 and 71 4 and 11 51 and 67
a Data are mean  SD (with the range in parentheses), except for entries in the “Segmental dystonia” row, in which
the values for both of the two patients are given.
lnL  n ln (pr) n ln (ps qr)11 1X
n ln (qs)m ln (p)m ln (q)XX 1 x
 (n m ) ln (p) (n m ) ln (q)11 1 XX X
n ln (r) n ln (s) n ln (ps qr) . (1)11 XX 1X
Substituting , , andr  p (1 p)d q  1 p s  1 r
gives a log likelihood that is a function of the two pa-
rameters p and d. This log likelihood can then be max-
imized with respect to both parameters, to estimate p
and d. In this case, equation (1) can be easily maximized,
by the EM algorithm, with respect to the parameters p
and r, since direct allele counts can be obtained by es-
timating the proportion of patient heterozygotes who
have allele 1 on a D chromosome, by . Theqr/(ps qr)
parameter d is then obtained by means of the formula
. Equation (1) can also be used to test hy-d  (r p)q
potheses about the parameter d. For example, we can
determine the largest value of d that is compatible with
the data, by finding the smallest value of d that leads to
rejection in a likelihood-ratio test (LRT) that compares
that value of d with the maximum-likelihood value of
d. We assume that such LRTs, calculated as twice the
log-likelihood difference, have a x2 distribution with 1
df.
Analysis of Clinical Data
We either applied x2 tests or, when appropriate, the
Fisher exact test to compare clinical patient data for
qualitative variables and have used a parametric t test
for quantifiable disease characteristics.
Results
A total of 85 patients with focal or segmental dystonia
(average age years, range 29–76 years) were54.4 11.0
analyzed, including 62 patients (72.9%) with spasmodic
torticollis, 9 patients (10.6%) with writer’s cramp, and
12 patients (14.1%) with cranial dystonia. The latter
group comprised 7 patients (8.2%) with blepharospasm
and 5 patients (5.9%) with Meige syndrome. Two pa-
tients (2.4%) had both cranial and cervical dystonia. All
patients were unrelated; 5 (5.9%) reported a positive
family history with at least one first-degree relative af-
fected by focal dystonia. Among the 85 patients, there
were more women than men ( [62%] vs.n  53 n 
[38%], respectively; ). Analysis of the different32 P ! .05
subgroups separately revealed that significantly more
women than men had cranial dystonia ( [92%]n  11
vs. [8%], respectively; ), whereas the fe-n  1 P ! .01
male:male ratio did not differ significantly in any of the
other groups. The mean age at disease onset was sig-
nificantly higher in the patients with cranial dystonia
( years) than in the patients with torticollis52.1 8.5
( years; ) but was not higher than42.8 12.4 P ! .005
in the patients with writer’s cramp ( years;46.0 14.1
). The subgroup of only two patients with seg-P 1 .05
mental dystonia was too small for separate analysis. The
clinical data are summarized in table 1.
The GAG deletion in the DYT1 gene was not found
in any of the patients studied. The results of our ge-
notype analysis for markers D18S1098 and D18S481
are given in table 2, along with those from two studies
by Leube et al. (1997a, 1997b). Leube et al. found that
the strongest evidence for disequilibrium was at locus
D18S1098: in their first study (Leube et al. 1997b), they
found that 60% of unphased patient chromosomes car-
ried allele 1 at D18S1098, compared with 28% of con-
trol chromosomes; in their second study (Leube et al.
1997a), they detected the same allele in 8 (73%) of 11
phased, disease-bearing chromosomes, compared with
32% of control chromosomes. In contrast, we found
allele 1 in only 37% of unphased patient chromosomes,
a frequency similar to the control frequencies reported
by Leube et al. (1997a, 1997b), whereas our controls
had a frequency of 45% for the same allele. Further-
more, we found no significant evidence of heterozygote
excess in our patient data ( ; not significant). The2x  .1
likelihood analysis gave a maximum-likelihood estimate
of , and all values of could be excluded.d  0 d 1 .18
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Table 2
Genotype and Allele Frequencies at Loci D18S1098 and D18S481,




Allele 111 1X XX
D18S1098:
Leube et al. (1997a):a
Patients ( )n  15 ) ) ) 73%
Controls ( )n  63 ) ) ) 32%
Leube et al. (1997b):b
Patients ( )n  15 27% (4) 67% (10) 6% (1) 60%
Controls ( )n  20 ) ) ) 28%
Present study:a
Patients ( )n  85 13% (11) 48% (41) 39% (33) 37%
Controls ( )n  85 19% (16) 52% (44) 29% (25) 45%
77 7X XX Allele 7
D18S481:
Leube et al. (1997a):a
Patients ( )n  15 ) ) ) 50%
Controls ( )n  63 ) ) ) 32%
Leube et al. (1997b):b
Patients ( )n  15 13% (2) 60% (9) 27% (4) 43%
Controls ( )cn  20 ) ) ) NR
Present study:a
Patients ( )n  85 25% (21) 44% (37) 32% (27) 46%
Controls ( )n  85 13% (11) 51% (43) 36% (31) 38%
a Sporadic cases without disease-chromosome status.
b Phased chromosomes from familial cases with disease-chromo-
some status ( for D18S1098; for D18S481).n  11 n  12
c NR  not reported.
The d value obtained from the data of Leube et al. is
.60; this value could be strongly rejected ( ).P ! .001
At locus D18S48l, our patients had an allele frequency
of 46% for allele 7, the associated allele. This frequency
is slightly lower than that in phased patient chromo-
somes in the study by Leube et al. (1997a), comparable
to that in their unphased patients (43%) (Leube et al.
1997b), and higher than that in their controls (32%)
(Leube et al. 1997a); in our controls, the frequency was
38%. However, neither our patient data nor the data
reported by Leube et al. (1997b) show a heterozygote
excess when submitted to Hardy-Weinberg analysis. In
fact, our patients showed a modest deficit of heterozy-
gotes. Because of the elevated allele frequency in pa-
tients, maximum-likelihood analysis gave a d estimate
of .21, whereas values 1.47 were rejected; a d value of
0 was not rejected ( , ). The two adja-2x  1.87 P 1 .10
cent markers, D18S1105 and D18S54, also showed no
evidence of either increased frequency or Hardy-Wein-
berg deviation.
Only 1/85 of our patients (a woman with blepharo-
spasm who was age 51 years at disease onset) shared,
with family K, the same haplotype at all four markers.
Genealogical analysis revealed that her parents had orig-
inated fromHolstein andMecklenburg,∼250miles from
the residence of family K (Emsland). In fact, at three of
the four markers tested, the most prevalent alleles found
in our patient sample (D18S1105, allele 7; D18S1098,
allele 6; and D18S54, allele 3) were different from those
that were found on the disease-bearing chromosome in
family K (D18S1105, allele 2; D18S1098, allele 1; and
D18S54, allele 2). When we took the former as the pu-
tatively overrepresented alleles in our population,we still
did not detect any deviation from Hardy-Weinberg ge-
notype frequencies.
Discussion
We analyzed 85 patients from northern Germany,
both clinically and genetically. Our data confirm the re-
sults from the literature—that is, that the female:male
ratio for patients seeking medical evaluation for cranial
dystonia is shifted toward women (Waddy et al. 1991;
Soland et al. 1996; Leube et al. 1997c). In agreement
with Soland et al. (1996), we found that, among the
affected men, there was a higher proportion of writer’s
cramp, although the number of women still exceeded
the number of men, even in this small subgroup. Patients
with cranial dystonia had a significantly higher age at
disease onset than was seen in patients with torticollis,
as has been described elsewhere (Waddy et al. 1991;
Leube et al. 1997c).
Among our 85 patients, 5 (5.9%) reported a positive
family history for focal dystonia. Similar numbers have
been reported in other studies; for example, 5 (5.5%)
of 91 patients with writer’s cramp had similarly affected
relatives, by history (Sheehy et al. 1988), and 11 (9.5%)
of 116 patients with spasmodic torticollis had a positive
family history of dystonia (Friedman and Fahn 1986).
Because of the unreliability of family-history reports,
however, these small numbers may not represent the ac-
tual frequency of patients with affected relatives. It has
also been shown that relatives of patients with dystonia
are often unaware of their own dystonic signs but that
many can be identified on careful clinical examination
(Waddy et al. 1991; Leube et al. 1997c).
None of our patients had the GAG deletion in the
DYT1 gene. Similarly, the DYT1 locus has been ex-
cluded, by linkage, in several families with adult-onset
idiopathic torsion dystonia (Bressman et al. 1994b;
Holmgren et al. 1995; Bressman et al. 1996), and the
GAG deletion was not found in 76 unrelated individuals
with late-onset dystonia (Ozelius et al. 1997). However,
because of phenotypic overlap between early-onset and
late-onset dystonia in individual cases, we recommend
screening for the GAG deletion in patients with early-
onset (age !40 years) focal dystonia, especially when it
starts in the arms and/or in patients with a positive fam-
ily history for dystonia.
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Linkage-disequilibrium studies—and the resulting
haplotype analyses—based on the comparison of allele
frequencies in controls versus those in affected individ-
uals have proved to be a powerful tool for the identi-
fication and cloning of various disease genes (MacDon-
ald et al. 1991; Ozelius et al. 1992). In addition, for a
dominant disease or a recessive disease with heteroge-
neity, linkage disequilibrium between markers and a
founder disease mutation can be identified on the basis
of deviations from Hardy-Weinberg equilibrium, as re-
cently has been shown for hereditary hemochromatosis
(Feder et al. 1996).
Both the linkage, in family K, to several markers on
chromosome 18p (Leube et al. 1996) and the description
of patients affected with dystonic symptoms as having
a deletion in chromosome 18p (Kakinuma et al. 1994;
Page et al. 1998) provide evidence that the short arm of
chromosome 18 may harbor a gene responsible for dys-
tonia. Nevertheless, in contrast to previously published
data (Leube et al. 1997a, 1997b), our analysis of 85
patients with focal dystonia who are from northern Ger-
many did not reveal any clear evidence for linkage dis-
equilibrium at the markers tested on chromosome 18p,
including those markers previously identified in family
K. Although marker D18S481 did show a modest excess
frequency of allele 7 in our patients versus that seen in
controls, this allele was only weakly associated with dys-
tonic symptoms in the data reported by Leube et al.
(1997a, 1997b). In contrast, at locus D18S1098 we
could find no evidence of disequilibrium; this marker
was most significantly associated in the data reported
by Leube et al. (1997a, 1997b). Indeed, combining our
data with those of Leube et al. gives a total allele fre-
quency of 43% for allele 1 in patients, versus 39% in
controls; this difference is not significant ( ,2x  1.73
). In their initial linkage-disequilibrium study,P 1 .20
Leube et al. (1997b) tested 22 markers. By chance alone,
with no corrections made for multiple testing, one would
expect to find linkage disequilibrium for 1/20 markers
(Bonferroni analysis). Several other aspects of the studies
by Leube et al. (1996, 1997a, 1997b) warrant reconsid-
eration. For example, shared haplotypes are inconsistent
among the 15 sporadic patients (Leube et al. 1997b), as
well as among affected individuals from the 15 European
families (Leube et al. 1997a). Only one sporadic patient
and one of the familial cases share the complete hap-
lotype with family K, whereas in six sporadic patients
and eight familial cases “haplotype sharing” is based on
a single marker (D18S1098, Dl8S481, or Dl8S54)
(Leube et al. 1997a, 1997b). In fact, on the basis of
allele frequencies for the CEPH population (GenomeDa-
tabase), 41% of northern Europeans share with family
K the same allele at the marker D18S1098, 13.1% share
with family K the alleles at both markers D18S1098 and
D18S481, and 1.7% share with family K the same hap-
lotype across all four markers. In our patient sample, 1
(1.2%) of 85 individuals shared the complete haplotype
with family K, as did one of the sporadic patients of
Leube et al. (1997b) and one of their European families
(Leube et al. 1997a). Given the population-migration
trends in central Europe during this century, it is difficult
to imagine a common founder mutation for DYT7 in
the central European population. Even though most of
the families in the studies by Leube et al. (1997a) seem
to be of German extraction, the population in that ge-
ographic area is large, and panmixia can be assumed.
Nevertheless, stable populations can be found, and sub-
sets of our patients are derived from such—mostly ru-
ral—areas. If a common ancestor were responsible for
DYT7 in a majority of German (or even central Euro-
pean) patients with focal dystonia, one would expect to
find, among the 85 patients from northern Germany
whom we tested, at least a subgroup of patients who
share the haplotype with family K.
Taken together, neither other studies nor our data sup-
port the conclusion that the majority of sporadic cases
of focal dystonia in northern Germany and central Eu-
rope are due to the same (founder) mutation, on chro-
mosome 18p, that has been described in family K (Leube
et al. 1996). Furthermore, it has not yet been clearly
demonstrated that the majority of cases of focal dystonia
are indeed genetic in origin, since, in an investigation in
the United Kingdom, careful examination demonstrated
that only 25% of the index cases had affected relatives
(Waddy et al. 1991). Another recent study showed an
increase in the proportion of sporadic cases with a pos-
itive family history—from 4 (23.5%) of 17, by history
alone, to 14 (82.4%) of 17, by examination (Leube et
al. 1997c). These data, however, may reflect an ascer-
tainment bias, since only 17 (3.5%) of 488 index pa-
tients agreed to examination of their relatives. However,
inheritance of focal dystonia is still consistent with an
autosomal dominant mode with low penetrance (Waddy
et al. 1991; Leube et al. 1997c), at least in some families.
As recently has been shown for the a-synuclein gene in
Parkinson disease (Polymeropoulos et al. 1997), a spe-
cific genetic defect may account for the disease in selected
families only and not for the majority of familial (Gasser
et al. 1997; Scott et al. 1997) or sporadic patients.
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